Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Reduced Intensity Conditioning (RIC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00898118
What this trial is testing

Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
European Working Group of MDS in Childhood 125
Testing effectiveness (Phase 2)Study completedNCT01496547
What this trial is testing

Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse AML

Who this might be right for
Acute Leukemia
Shanghai Jiao Tong University School of Medicine 47
Very early researchEnded earlyNCT00881556
What this trial is testing

Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Epidermolysis Bullosa
Columbia University 3
Not applicableStudy completedNCT00723333
What this trial is testing

Bone Marrow Transplant Chart Review for RIC

Who this might be right for
Myelofibrosis
University of Utah 30
Not applicableLooking for participantsNCT01666080
What this trial is testing

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

Who this might be right for
Hematologic DisordersHemoglobinopathiesImmunodeficiencies
Masonic Cancer Center, University of Minnesota 30
Not applicableLooking for participantsNCT06803745
What this trial is testing

Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)

Who this might be right for
Acute LeukemiaAcute Lymphoblastic Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 160
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07598110
What this trial is testing

FLUDARABINE-TREOSULFAN REDUCED INTENSITY CONDITIONING REGIMEN PRIOR HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST TRANSPLANTATION CYCLOPHOSPHAMIDE FOR OLDER AND/OR FRAIL PATIENTS WITH AML

Who this might be right for
Acute Myeloid Leukemia
Institut Paoli-Calmettes 77
Large-scale testing (Phase 3)Study completedNCT00822393
What this trial is testing

Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
medac GmbH 570
Testing effectiveness (Phase 2)Looking for participantsNCT05805605
What this trial is testing

Allo HSCT Using RIC and PTCy for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaBiphenotypic Acute Leukemia+15 more
Masonic Cancer Center, University of Minnesota 56
Testing effectiveness (Phase 2)UnknownNCT02766868
What this trial is testing

Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALL

Who this might be right for
Lymphoblastic Leukemia, Acute, Adult
Shanghai Jiao Tong University School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT01244906
What this trial is testing

Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant

Who this might be right for
Hematologic Neoplasms
Northside Hospital, Inc. 26
Testing effectiveness (Phase 2)Ended earlyNCT03367546
What this trial is testing

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases

Who this might be right for
Sickle Cell DiseaseThalassemiaHigh Risk Hematologic Disorders+2 more
Masonic Cancer Center, University of Minnesota 5
Early research (Phase 1)Study completedNCT02996773
What this trial is testing

Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndromes+10 more
University of Arizona 50
Not applicableStudy completedNCT00682799
What this trial is testing

Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC)

Who this might be right for
Refractory Cytopenia of ChildhoodReduced Intensity Conditioning (RIC)Myelodysplastic Syndrome (MDS)+1 more
Charlotte Niemeyer, MD 112
Large-scale testing (Phase 3)Enrolling By InvitationNCT05674539
What this trial is testing

Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia, AdultMyelodysplastic Syndrome(MDS)Allogeneic Hematopoietic Stem Cell Transplantation
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 200
Testing effectiveness (Phase 2)UnknownNCT06468267
What this trial is testing

RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.

Who this might be right for
Peripheral T Cell Lymphoma
Xianmin Song, MD 50
Testing effectiveness (Phase 2)Study completedNCT01998633
What this trial is testing

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

Who this might be right for
Hemophagocytic LymphohistiocytosisChronic Active Epstein-Barr Virus InfectionChronic Granulomatous Disease+3 more
Medical College of Wisconsin 47
Testing effectiveness (Phase 2)Looking for participantsNCT06928662
What this trial is testing

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Who this might be right for
Acute Myeloid LeukemiaAcute Undifferentiated LeukemiaMixed Phenotype Acute Leukemia+11 more
Fred Hutchinson Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT02988466
What this trial is testing

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota 78
Testing effectiveness (Phase 2)Ended earlyNCT00548717
What this trial is testing

Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft-vs-Host Disease
Dana-Farber Cancer Institute 15
Next Page